We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QUAD:NYSEQuad Graphics, Inc Analysis

Data as of 2026-09-05 - not real-time

$10.70

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Quad/Graphics, Inc. is priced at $10.70 and its moving averages line up in bullish order, the shorter sitting above the longer. It has gained 28.3% over the past 30 days. RSI sits at 69.7, which reads as approaching overbought, and MACD momentum is bearish. Watch $9.66 as support and $10.87 as the nearer resistance level.
The shares look undervalued, trading on 16.2 times earnings below a sector average of 28.5. Analyst price targets sit 23.1% above the current price. The 3.86% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 45.5%, a beta of 0.45 and a maximum drawdown of 24.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.

Top Market Events

Realizes Net Sales Increase in the Second Quarter and Reaffirms Full-Year 2026 Financial Guidance SUSSEX, Wis.Updated Jul 21, 2026 0 SUSSEX, Wis., July 21, 2026 /PRNewswire/ -- Quad/Graphics, Inc. NYSE: QUAD "Quad" or the...New Salt Lake City facility strengthens service for packaging clients across the U.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 7.43
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 16.2 versus sector average of 28.5
  • Trading above the 200-day average of 7.43

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 16.2 versus sector average of 28.5
  • Analyst targets imply +23.1% versus the current price
  • Return on equity of 29.5%

Key Metrics & Analysis

Financial Health

Revenue Growth1.00%
Profit Margin1.31%
P/E Ratio16.2
ROE29.48%
ROA5.51%
Debt/Equity376.50
P/B Ratio4.4
Op. Cash Flow$96.6M
Free Cash Flow$89.7M
Industry P/E28.5

Technical Analysis

TrendBullish
RSI69.7
Support$9.66
Resistance$10.87
MA 20$10.11
MA 50$9.38
MA 200$7.43
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$14.08
Target Price$13.17
Upside/Downside23.05%
GradeUndervalued
TypeBlend
Dividend Yield3.86%

Risk Assessment

Beta0.45
Volatility45.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.